GlaxoSmithKline Uses Clinical Graphics Solution Developed by Insightful Corporation

GSK using Insightful’s clinical graphics solution for communicating safety and efficacy information in clinical data

Seattle, WA - April 29, 2008 -

Insightful Corporation (NASDAQ: IFUL), a leading provider of predictive analytics and reporting solutions, announced today that GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical and healthcare companies, is using a clinical graphics solution developed by Insightful and S-PLUS®, Insightful’s software platform for statistical data analysis and predictive analytics, to speed the design, analysis, and reporting of clinical trial data.

"We are committed to this S-PLUS graphics solution to assist our statisticians and scientists in understanding our data, and to improve the communication of results," said Dr. Roger F. Liddle, Vice President of Discovery Biometrics at GSK and sponsor of GSK’s clinical graphics initiative. “As of end of 2007, we have over 200 statisticians, programmers and epidemiologists trained. We are seeing significant uptake of the S-PLUS graphics solution, with the majority of users finding it an easy way to produce high quality graphs. The clinical graphics our staff are producing are being used by GSK statisticians, clinicians, and publishing staff in several critical areas, including data analysis, presentation, submission, and publication.”

Insightful’s clinical graphics solutions are designed to enable effective communication of clinical data in journals, presentations, and regulatory submissions through point-and-click creation of advanced graphics and seamless integration with existing exploratory, presentation, and production reporting environments. Important benefits of these clinical graphics solutions include the ease of use for those without specialized programming skills and streamlined graphics production across all clinical and reporting areas, minimizing the time and cost incurred by expensive and scarce statistical programming resources.

GSK is employing Insightful’s S-PLUS platform and advanced statistical graphics libraries, including Trellis™ technology and a comprehensive graphics taxonomy collection. These libraries deliver industry-standard graphics for interpreting and communicating information in clinical data.

"GSK is a world-recognized leader in the use of statistical graphics for analysis, presentation, and communication of information in clinical data," said Jeff Coombs, president and CEO of Insightful. "The clinical graphics solution that we built for GSK on top of our S-PLUS platform provides them with an integrated solution for extracting and communicating information in clinical data across their organization and to their clinical and regulatory partners. We are pleased to have the opportunity to assist GSK in this core function of their business."

Statistical analysis software